The Best Non-Surgical Solutions for Underarm Sweating in 2026

arm sweating

Underarm hyperhidrosis — excessive sweating of the axillary region — is one of the most common yet under-discussed medical complaints in dermatology. It’s estimated to affect roughly 4.8% of the U.S. population, and for many, it does far more than dampen a shirt. It shapes wardrobe choices, complicates job interviews, and quietly chips away at self-confidence in everyday interactions. The encouraging news is that 2026 represents one of the most active periods in years for non-surgical hyperhidrosis treatment, with newer FDA-cleared options joining a maturing lineup of proven therapies. As someone who follows this space closely, I want to walk through what’s actually working right now — not hypothetical future treatments, but options patients can access today — so you can have a more informed conversation with your dermatologist.

Surgery, particularly endoscopic thoracic sympathectomy, has always been viewed as a last resort for underarm sweating because it’s irreversible and carries a real risk of compensatory sweating elsewhere on the body. Fortunately, the non-surgical toolkit has grown substantially, giving patients far more room to find relief before ever considering an operating table.

 

Why Non-Surgical Treatment Should Come First

Underarm hyperhidrosis is typically classified as primary focal hyperhidrosis, meaning it stems from overactive signaling in the sympathetic nervous system rather than an underlying disease. Because the sweat glands themselves are structurally normal — just overstimulated — most non-surgical treatments work by either physically blocking the sweat duct, chemically interrupting the nerve signal that triggers sweating, or using targeted energy to reduce the sweat gland’s ability to function. This gives dermatologists several non-invasive levers to pull before surgery ever needs to be discussed.

1. Prescription-Strength Antiperspirants: The Starting Point

For many patients, treatment still begins with topical aluminum chloride antiperspirants, applied at night to dry skin. These work by forming a temporary plug within the sweat duct. While over-the-counter versions are often insufficient for true hyperhidrosis, prescription-strength formulations (typically 10–20% aluminum chloride) can meaningfully reduce sweating for mild-to-moderate cases. The main drawback is skin irritation, especially with regular use, and many patients find the effect diminishes over time as sweat glands adapt.

2. Glycopyrronium Topical Treatments (Qbrexza)

Glycopyrronium cloths remain a well-established topical anticholinergic option. Each individually packaged wipe is applied once daily to the underarms and works by blocking the receptors responsible for activating sweat glands. Clinical data compiled by the International Hyperhidrosis Society shows that once-daily use over four weeks can meaningfully decrease sweating severity and reduce sweat volume in most patients. It’s a convenient, needle-free option, though localized side effects like dry mouth or mild skin irritation can occur since some of the active ingredient is absorbed systemically.

3. Sofpironium Gel (Sofdra): The Newer Topical Option

One of the more significant additions to the hyperhidrosis toolkit in recent years is sofpironium gel, a topical anticholinergic approved for primary axillary hyperhidrosis. Unlike older systemic anticholinergics, sofpironium is a “retrometabolic” drug — designed to act locally on the skin and then break down rapidly into inactive compounds before it can cause body-wide side effects. It works by selectively blocking M3 muscarinic receptors in the sweat glands.

Pooled data from phase 3 trials found that a majority of patients achieved a clinically meaningful reduction in sweating, with a favorable side-effect profile compared to older topical anticholinergics — dry mouth was reported in a minority of users, and rates were generally lower than with some earlier-generation treatments. For patients who found glycopyrronium wipes too irritating or who want a gel-based alternative, sofpironium has become a popular next step.

4. Botulinum Toxin Injections: Still the Gold Standard

Despite the arrival of newer devices and topicals, botulinum toxin injections (Botox and similar formulations) remain the most well-established, FDA-approved, in-office treatment for moderate-to-severe axillary hyperhidrosis — and for good reason. The toxin works by blocking acetylcholine release at the nerve endings that trigger sweat glands, effectively silencing the signal in the treated area.

What keeps this treatment at the top of most specialists’ recommendations:

  • Consistent, well-documented efficacy, with most patients seeing an 80–90% reduction in underarm sweating.
  • Long-lasting relief, typically 6 to 9 months per session before a touch-up is needed.
  • Minimal downtime — the procedure takes roughly 20–30 minutes using a fine grid of shallow injections.
  • Decades of safety data across both cosmetic and medical use.

The main downsides are the need for repeat sessions, mild discomfort during injection, and cost if insurance coverage isn’t secured (though many insurers now cover it once topical treatments have failed).

5. Brella SweatControl Patch: The Newest Non-Invasive Device

The most talked-about recent addition to the field is the Brella SweatControl Patch, an FDA-cleared, single-use device that takes a completely different mechanical approach. Rather than relying on chemical blockade, Brella uses the company’s targeted alkali thermolysis (TAT) technology: a thin sodium sheet is applied to the underarm by a healthcare provider for about three minutes. When the sodium contacts the water in sweat, it generates precisely localized thermal energy that reduces the sweat glands’ activity in that specific area.

In the pivotal SAHARA study — a randomized, double-blind, multicenter trial involving 110 adults with primary axillary hyperhidrosis — the treatment demonstrated meaningful sweat reduction with a favorable tolerability profile, and effects were maintained for three months or longer in many participants. Because it’s needle-free, requires no anesthesia, and takes just a few minutes per underarm, it appeals to patients who want a fast, low-commitment in-office option.

One important caveat for 2026: patients interested in Brella should confirm current availability with their provider, as the treatment has experienced some supply and access disruptions following a change in company ownership. It’s worth calling ahead before booking an appointment specifically for this option.

6. Iontophoresis (More Common for Palms, Sometimes Used for Underarms)

Iontophoresis uses a mild electrical current passed through water or a moistened pad to temporarily reduce sweat gland activity. It’s most widely used for palms and soles, where it can be self-administered at home, but is occasionally used for underarms as well. It requires regular maintenance sessions and doesn’t offer the same convenience as topical or injectable options, which is why it’s typically considered when other non-surgical treatments aren’t well tolerated.

7. Oral Anticholinergics: A Broader, Systemic Option

For patients whose sweating isn’t confined to the underarms — or who want a single treatment covering multiple areas — oral anticholinergic medications such as glycopyrronium or oxybutynin remain an option. These work by blocking acetylcholine receptors throughout the body, reducing overall sweat production. They can be effective, particularly for multisite hyperhidrosis, but because the effect is systemic rather than localized, side effects like dry mouth, blurred vision, and constipation are more common and tend to limit long-term use for some patients.

8. Microwave Thermolysis (miraDry)

MiraDry uses targeted microwave energy delivered through a handheld device to permanently reduce the number of sweat glands in the underarm. Unlike the treatments above, its effects are intended to be long-lasting to permanent, since destroyed sweat glands don’t regenerate. Long-term patient satisfaction data has been favorable, with high recommendation rates and sustained improvements in quality of life reported years after treatment. It typically requires one to two sessions and some temporary swelling or tenderness afterward, but no ongoing maintenance is needed once the treatment course is complete — making it a popular choice for patients who want a “treat it and forget it” non-surgical solution.

 

Choosing the Right Option: A Practical Framework

With so many legitimate options now available, the right choice comes down to a few key questions your dermatologist will typically walk through:

  • How severe is the sweating, and is it confined to the underarms or more widespread? Localized treatments (Botox, Brella, topical agents) work best for isolated axillary sweating; oral medication may suit multisite cases.
  • Do you want a one-time or infrequent solution, or are you comfortable with regular touch-ups? MiraDry and Brella offer longer intervals between treatments; topical agents require daily or near-daily use.
  • How do you feel about needles? Botox involves injections; Brella, topicals, and iontophoresis do not.
  • What’s your budget and insurance coverage? Coverage varies significantly by treatment and insurer, so it’s worth checking before committing to a plan.

For most patients, a stepwise approach still makes sense: start with prescription topical treatment, escalate to Botox injections or a device-based option like Brella or miraDry if needed, and reserve oral medication or surgical referral for cases that don’t respond to localized therapy.

 

Final Thoughts

The non-surgical landscape for underarm sweating in 2026 is more robust than it’s ever been. Between long-standing options like Botox and iontophoresis, well-established topicals like glycopyrronium, and newer arrivals like sofpironium gel and the Brella patch, most patients with axillary hyperhidrosis can now find meaningful, lasting relief without ever stepping into an operating room. If underarm sweating is affecting your confidence or daily routine, don’t wait — a conversation with a board-certified dermatologist can quickly clarify which of these options fits your situation best.

FAQ

What is the most effective non-surgical treatment for underarm sweating?

Botulinum toxin injections remain the most consistently effective, well-studied option for moderate-to-severe axillary hyperhidrosis, typically reducing sweat production by 80–90% for 6 to 9 months per session. Newer options like Brella and sofpironium gel are strong alternatives, particularly for patients who prefer a needle-free approach.

Botox works by chemically blocking the nerve signal that triggers sweat glands and involves a series of injections. Brella uses heat generated from a reaction between sodium and sweat to reduce sweat gland activity, applied via a patch with no needles involved. Both are performed in-office, but they work through entirely different mechanisms.

Brella received FDA clearance for primary axillary hyperhidrosis, but availability has been inconsistent in 2026 due to changes in the manufacturing company’s ownership. It’s best to confirm current availability with a local provider before scheduling.

Because miraDry is designed to permanently reduce the number of sweat glands, its effects are intended to be long-lasting to permanent for most patients, unlike topical or injectable treatments that require repeat sessions.

Yes. Many dermatologists combine treatments — for example, using a prescription antiperspirant between Botox sessions — to maintain results and reduce breakthrough sweating as an injection’s effect gradually wears off.

They can meaningfully reduce sweating for many patients, but generally produce less dramatic results than Botox and require consistent daily or near-daily application to maintain effect. They’re often a good starting point or an option for patients who prefer to avoid injections.

Coverage varies by insurer and treatment. Botox for hyperhidrosis is frequently covered once topical treatments have been tried and failed, since it’s an FDA-approved indication. Newer devices and topicals may have more variable coverage, so it’s worth checking directly with your insurance provider.

Surgical options like endoscopic thoracic sympathectomy are generally reserved for severe cases that haven’t responded adequately to non-surgical treatments, given the risk of compensatory sweating and the permanent nature of the procedure. Most patients find sufficient relief through non-surgical options before surgery becomes necessary.

X
Talk with our AI agent.